The Swiss-based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia.

Contact Vendor

Peptide aggregation: A complex topic

The understanding of the oligomerization and aggregation potential of peptide candidates is key for the development of long acting and stable drugs. In this on-demand webinar, you will learn more about:

The fundamental of aggregation behaviors
Techniques to monitor and measure peptide aggregates
How to get an operating window to mitigate risk of aggregation

11/14/2023

View Content

Greener Purification at Large-Scale: An Oligonucleotide Case Study

Discover how Bachem enabled one client to succeed by providing a solution for manufacturing multi-ton oligonucleotide API with high throughput and a reduced environmental footprint.

5/15/2023

View Content